Myrexis(OTC) MYRX

Market Cap$206.90K

Since IPO (2009)-97%

5 Year-88%

1 Year+2,900%

1 Month+650%

$0.01

+0.00%

+0.00Today

Myrexis last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-07-29

Myrexis stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-14.29%	USD 0.01	2026-07-22
1 month	+650%	USD 0.00	2026-06-22
3 month	+1,400%	USD 0.00	2026-04-27
Year to date	+1,400%	USD 0.00	2025-12-24
1 year	+2,900%	USD 0.00	2025-07-25
3 year	+71.43%	USD 0.00	2023-07-27
5 year	-88.12%	USD 0.05	2021-07-30
Since inception	-97.19%	USD 0.21	2009-06-12

Myrexis Financials at a Glance

Market Cap

$206.90K

Revenue (TTM)

$0.00

Net Income (TTM)

-$11.62M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.81 (Low)

Dividend

$0.00

Beta (Volatility)

-3.81 (Low)

Price

$0.01

Volume

3,000

Open

$0.01

Price

$0.01

Volume

3,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Feb 7, 2025

Dividend

$0.00

Beta (Volatility)

-3.81 (Low)

Price

$0.01

Volume

3,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Feb 7, 2025

MYRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Myrexis

Myrexis, Inc. is a company focused on identifying and financially supporting ventures in the life sciences sector. Formerly known as Myriad Pharmaceuticals, Inc., the company rebranded in July 2010 and is headquartered in New York City.

Products and Services

Investment in life sciences ventures
Evaluation of emerging technologies
Financial backing for innovative projects

Growth Outlook

Strong cash position with $1.14 million in cash and short-term investments
Current ratio of 16.72 indicates excellent liquidity
Potential for strategic partnerships in the life sciences sector

Financial Highlights

Recent quarterly net income of -$151,000
Trailing twelve months (TTM) cash flow negative at -$2.26 million
Market capitalization of approximately $27,583

Myrexis, Inc. operates in a niche market with a focus on life sciences, which presents unique investment opportunities. The company's strong liquidity position, as indicated by a current ratio of 16.72, suggests it can meet short-term obligations effectively. Despite recent losses, the potential for strategic partnerships and investments in innovative projects may drive future growth. The company’s cash reserves provide a buffer for navigating challenges while exploring new ventures. Investors may find Myrexis, Inc. an intriguing option within the life sciences investment landscape.

AI Generated • Jul 19, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

New York City, NY 10020, US

MYRX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-25.67%

Return on Capital

-1031.04%

Return on Assets

-939.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$206.90K

Shares Outstanding

34.48M

Volume

3.00K

Avg. Volume

12.09K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$11.99M

EBITDA

-$11.97M

Operating Cash Flow

-$12.97M

Capital Expenditure

$0.00

Free Cash Flow

-$12.97M

Cash & ST Invst.

$1.21M

Total Debt

$0.00

Myrexis Performance Analysis

Myrexis sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2012-09-30	N/A
Q2	2012-12-31	N/A
Q3	2013-03-31	N/A
Q4	2013-06-30	N/A

Myrexis sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2012-09-30	-2189.4%
Q2	2012-12-31	-38.5%
Q3	2013-03-31	38.9%
Q4	2013-06-30	95.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q4 2012YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$206.90K

N/A

Market Cap/Employee

$206.90K

N/A

Employees

N/A

Net Income

-$151.00K

+96.6%

EBITDA

-$153.00K

+1.3%

Quarterly Fundamentals

Name

Q4 2012YOY CHG

Total Cash

$1.21M

-98.6%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-9.39%

N/A

Return on Invested Capital

-10.31%

N/A

Free Cash Flow

-$304.00K

+95.8%

Operating Cash Flow

-$304.00K

+95.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OOGIC2E Energy, Inc.

OOGIC2E Energy, Inc.$0.00+0.00%

CNHCChina Health Management Corp.

CNHCChina Health Management Corp.$0.00+0.00%

AAPTAll American Pet Company, Inc.

AAPTAll American Pet Company, Inc.$0.00+9900.00%

OWVIOne World Ventures, Inc.

OWVIOne World Ventures, Inc.$0.00+0.00%

ALDAAtlantica, Inc.

ALDAAtlantica, Inc.$0.05+0.00%

LTUSLotus Pharmaceuticals, Inc.

LTUSLotus Pharmaceuticals, Inc.$0.00-24.05%

TAKDTransAKT Ltd.

TAKDTransAKT Ltd.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PLTRPalantir Technologies

PLTRPalantir Technologies$162.66+0.29%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$125.33+0.09%

NVDANvidia

NVDANvidia$211.94+0.03%

INTCIntel

INTCIntel$100.86+0.11%

AMIXAutonomix Medical

AMIXAutonomix Medical$19.50+4.34%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$8.07+0.03%

NOKNokia

NOKNokia$9.92+0.06%

Questions About MYRX

What is the current price of Myrexis?

Myrexis is trading at $0.01 per share.

What is the 52-week range for Myrexis?

Over the past 52 weeks, Myrexis has traded between $0.00 and $0.01.

How much debt does Myrexis have?

Myrexis total debt is unavailable.

How much cash does Myrexis have on hand?

Myrexis does not have cash on hand data available.

What is Myrexis’s dividend yield?

Myrexis does not currently have a dividend yield.

Myrexis(OTC) MYRX

Myrexis Financials at a Glance

MYRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Myrexis

MYRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Myrexis Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MYRX

What is the current price of Myrexis?

What is the 52-week range for Myrexis?

How much debt does Myrexis have?

How much cash does Myrexis have on hand?

What is Myrexis’s dividend yield?

Premium Investing Services